D. Walker

IMPACT OF A MODEL SOIL ON THE BIOTRANSFORMATION OF 2,4,6-TRINITROTOLUENE AND ITS AMINE METABOLITES

D. K. Walker, D. Walker, 2004 .

Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man.

P. Wright, G. Muirhead, M. Ackland, 1999, Xenobiotica; the fate of foreign compounds in biological systems.

PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals

P. Taupin, D. Walker, B. K. Park, 2009 .

The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development.

D. K. Walker, D K Walker, D. Walker, 2004, British journal of clinical pharmacology.

Importance of metabolic stability and hepatic distribution to the pharmacokinetic profile of amlodipine.

D. Smith, M. Humphrey, D. Walker, 1994, Xenobiotica; the fate of foreign compounds in biological systems.

PEGylation of somatropin (recombinant human growth hormone): Impact on its clearance in humans

R. Xie, R. Webster, A. Edgington, 2008, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetics of a series of bis(methanesulphonamido-arylalkyl)amines in the beagle dog.

D A Smith, D A Stopher, D. Smith, 1996, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetics and metabolism of a selective PDE5 inhibitor (UK-343,664) in rat and dog

K. Beaumont, P. Wright, K. Evans, 2001, Xenobiotica; the fate of foreign compounds in biological systems.

Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay.

J. Arrowsmith, D. Smith, G. Aherne, 1991, Journal of pharmaceutical and biomedical analysis.